*Toxoplasma gondii* is an obligate intracellular protozoan parasite with a global distribution in humans and other mammals. Although this parasite most often causes subclinical infection, primary infection during pregnancy can induce fetal damage and abortion in both humans and animals. *T. gondii* is a well-known inducer of type 1 cytokines, and while these cytokines are required to survive infection, their over-production can be harmful and even lethal \[[@b1-kjp-57-2-201],[@b2-kjp-57-2-201]\].

Mast cells are abundant in the skin, mucosa of the digestive and respiratory tracts and conjunctiva. These cells provoke IgE-mediated allergic responses and are involved in the control of helminth infections of the gastrointestinal tract. They play a key role in innate and adaptive immunity \[[@b3-kjp-57-2-201],[@b4-kjp-57-2-201]\] and have been shown to induce acute inflammatory reactions in mice in response to intraperitoneal injection of *T. gondii* \[[@b5-kjp-57-2-201]\]. Mast cells also protect the host when *T. gondii* is introduced by the oral route \[[@b3-kjp-57-2-201]\]. Mediators produced by activated mast cells may reduce acute inflammation and stimulate parasite clearance in *T. gondii* infections \[[@b6-kjp-57-2-201]\]. On the other hand, *T. gondii* itself inhibits mast cell degranulation by suppressing the mobilization of intracellular Ca^2+^ by phospholipase C \[[@b7-kjp-57-2-201]\]. So, the overall effect of mast cells on *T. gondii* infections is uncertain. In addition, it is not known whether *T. gondii* lysates can induce inflammatory responses in the mast cell leukaemia cell line, HMC-1. The aim of this study was to evaluate whether *T. gondii* lysates induce the activation of HMC-1 cells to release cytokines and nitric oxide.

*T. gondii* (RH strain) tachyzoites were maintained by intra-peritoneal infection of ICR mice (Osan, Korea). Tachyzoites were harvested from the mice, washed with PBS and centrifuged at low and high speeds (500 g and 3,000 g) for 5 min to remove peritoneal cells. To prepare *T. gondii* lysate, the tachyzoites were frozen and thawed 3 times and ultrasonicated at 100% amplitude, 0.75 cycles, 7--10 times, until the tachyzoites were completely disrupted. The sonicate was centrifuged at 10,000 g for 1 hr, and the supernatant was filtered through a 0.2 μm membrane (Millipore, Bedford, Massachusetts, USA). Protein concentrations were determined with the Bradford assay (Bio-Rad, Hercules, California, USA).

Human leukemic mast cells (HMC-1) were grown in IMDM supplemented with 10% FBS at 37°C in a 5%-CO~2~ incubator. To examine cytokine and iNOS mRNA expression, HMC-1 cells (1.5×10^6^/well) were pretreated with IFN-γ (5 μg/ml, ProSpec, East Brunswick New Jersey, USA) for 1 hr and then stimulated with an aliquot of *T. gondii* lysate (50 μg/ml) or LPS (10 μg/ml, Sigma, St Louis, Missouri, USA). As a positive control, the HMC-1 cells were incubated with PMA (100 nm/ml) and A23187 (10 μm/ml). Total RNA was extracted from the cells using Trizol reagent (Invitrogen, Carlsbad, California, USA) and 200 μl chloroform (Sigma Aldrich, St. Louis, Missouri, USA). cDNAs were synthesized and reverse-transcribed using RT Premix and PCR Premix (iNtRON Biotechnology, Seongnam, Korea). Primer sequences were as follows; β-actin (5′-CCA GAG CAA GAG AGG TAT CC-3′ and 5′-CTG TGG TGG TGA AGC TGT AG-3′), human IL-8 (5′-GCC AAG AGA ATA TCC GAA CT-3′ and 5′-AAA GTG CAA CCA CAT GTC CT-3′), MCP-1 (5′-TCT GTG CCT GCT GCT CAT AG-3′ and 5′-GCT GCA GAT TCT TGG GTT GT-3′), IL-4 (5′-CCC TTT CGG CAA AAT CCT CC-3′ and 5′-AGG AAT ACA GTG CAG CTT ACC A-3′), TNF-α (5′-ACT CTT CTG CCT GCT GCA CTT TGG-3′ and 5′-GTT GAC CTT TGT CTG GTA GGA GAC GG-3′), iNOS (5′-AGC ATG AGC CCC TTC ATC AAT-3′ and 5′-CTG TTT CAA CGA CCT CCG GG-3′), and GAPDH (5′-GTC AGT GGT GGA CCT GAC CT-3′ and 5′-AGG GGT CTA CAT GGC AAC TG-3′). PCR conditions were initial DNA denaturation at 94°C for 5 min followed by 35 rounds of denaturation at 98°C for 15 sec, and annealing for 30s at 58°C for β-actin, GAPDH & iNOS, 56°C for IL-8 & IL-4, 55°C for MCP-1, and 62°C for TNF-α, and extension at 72°C for 35 sec.

To measure IL-8, MCP-1, TNF-α and IL-4 proteins, HMC-1 cells were pretreated with IFN-γ followed by exposure to *T. gondii* lysate or LPS for 18 hr or 24 hr. Supernatants were collected and stored at −20°C and cytokines were measured by ELISA (BD Biosciences, San Diego, California, USA).

Western blot analysis with monoclonal antibodies was used to detect expression of IL-8 receptor (CXCR1 and CXCR2) on HMC-1 cells which were pretreated with IFN-γ for 1 hr followed by *T. gondii* lysate or LPS. After incubation, the cells were harvested and lysed in PRO-PREP protein extraction solution (iNtRON Biotechnology, Seongnam, Korea). Equal amounts of protein were denatured and separated by SDS--PAGE on 10% polyacrylamide gels and transferred to Immune-Blot1 PVDF membranes (Bio-Rad, Quarry Bay, HongKong). The membranes were probed with anti-CXCR1 and anti-CXCR2 antibodies (1:1,000; Abcam, Cambridge, UK), or β-actin polyclonal antibody (1:3,000; Abcam, Cambridge, Massachusetts, USA) overnight at 4°C followed by goat anti-rabbit IgG polyclonal antibody (1:10,000; ADISAB-300-J, Enzo Life Sciences, New York, USA) for 1 hr at room temperature. The blots were visualized using Chemiluminescent Sensitive Plus HRP Microwell and/or Membrane Substrate (SurModics, Minneapolis, Minnesota, USA), and signals were measured with a Chemi-Doc1 (Bio-Rad).

For measuring nitric oxide, HMC-1 cells was pretreated with IFN-γ followed by *T. gondii* lysate or LPS for 3 hr, 6 hr, 18 hr or 24 hr and supernatants were collected. NO was determined as nitrite using Griess reagent \[[@b8-kjp-57-2-201]\].

Statistical analyses were performed with SPSS, version 21 (IBM, Chicago, Illinois, USA). The Mann-Whitney U test was used to compare results, and *P*-values\<0.05 were considered statistically significant. Data are expressed as means±SDs of three independent experiments.

In this experiment, up-regulation of IL-8 mRNA and increased secretion of IL-8 were observed in the *T. gondii*-treated HMC-1 cells 6 hr and 18 hr post inoculation (PI), respectively. However the IL-8 levels of HMC-1 cells stimulated with LPS as positive control were significantly higher than those of the of *T. gondii*-stimulated cells. Up-regulations of MCP-1 mRNA and protein were also observed in the HMC-1 cells exposed to *T. gondii* lysate or LPS. Similarly, enhanced TNF-α mRNA expression and increased TNF-α secretion were noted in supernatants of HMC-1 cells treated with *T. gondii* lysate. IL-4 mRNA was also increased by incubation with *T. gondii* lysate for 24 hr, and IL-4 protein increased in the supernatants of treated HMC-1 cells ([Fig. 1A, B](#f1-kjp-57-2-201){ref-type="fig"}). To investigate the expression of chemokine receptors for IL-8, CXCR1 and CXCR2 production was analyzed by western blotting after treatment of HMC-1 cells with *T. gondii* lysate or LPS for 1 hr. Both CXCR1 and CXCR2 increased in response to *T. gondii* lysate ([Fig. 1C](#f1-kjp-57-2-201){ref-type="fig"}).

The results in [Fig. 2A](#f2-kjp-57-2-201){ref-type="fig"} show that iNOS mRNA increased in HMC-1 cells treated with *T. gondii* lysate for 3 hr, and then gradually disappeared. In LPS-treated cells, iNOS mRNA continued to increase between 3 hr and 24 hr of incubation although at a decreasing rate. Maximal NO production in HMC-1 cells treated with *T. gondii* lysate or LPS was observed after 3 hr of stimulation ([Fig. 2B](#f2-kjp-57-2-201){ref-type="fig"}).

In *T. gondii* infections, immune cells including neutrophils, monocytes and macrophages are activated, and also these cells are targets of *T. gondii* \[[@b9-kjp-57-2-201],[@b10-kjp-57-2-201]\]. *T. gondii* down-regulates type I immune responses, blocking production of pro-inflammatory cytokine including IFN-γ in macrophages and dendritic cells \[[@b11-kjp-57-2-201]\]. Mast cells are abundant in the intestinal mucosa and play an important role in protective immune responses to oral infection by *T. gondii* \[[@b3-kjp-57-2-201]\]. Exposure to *T. gondii* causes mast cell to activate, degranulate and release mediators, proteases and cytokines \[[@b12-kjp-57-2-201]\]. Increases in mast cells numbers may be involved in the balance between inflammation and wound healing \[[@b13-kjp-57-2-201]\].

In the current study we found that IL-8 and MCP-1 secretion was up-regulated after 18 hr exposure to *T. gondii* lysate. This result is in agreement with our previous report that infection with *T. gondii* tachyzoites leads to increased secretion of IL-8 and MCP-1 by HeLa cells and fibroblasts \[[@b14-kjp-57-2-201]\]. Up-regulation of TNF-α and IL-4 mRNAs was observed in HMC-1 cells treated with *T. gondii* lysate for 18 hr and 24 hr, respectively. Production of both cytokines increased in *T. gondii* lysate- or LPS-treated HMC-1 cells indicating that *T. gondii* lysate induces inflammatory effect in the cells. *T. gondii* lysate alone did not increase cytokine production in HMC-1 cells. However, pre-treatment of IFN- γ resulted in increased cytokine production in the cells. Therefore, IFN-γ was thought to be acted as a trigger for HMC-1 cells in cytokine production by *T. gondii* lysate.

The functions of chemokines induced by intracellular pathogens include leukocyte recruitment, cell mediated immunity and anti-protozoal activity. IL-8 induces a rapid and transient increase of Ca^2+^ in mast cells. HMC-1 cells express the CXCL8 chemokine receptors, CXCR1 and CXCR2 \[[@b15-kjp-57-2-201]--[@b18-kjp-57-2-201]\]. Increased levels of these receptors were observed on HMC-1 cells stimulated with *T. gondii* lysate for 1 hr ([Fig. 1C](#f1-kjp-57-2-201){ref-type="fig"}).

The release of mediators by mast cell activation plays an important role in modulating inflammation during *T. gondii* infection \[[@b6-kjp-57-2-201],[@b16-kjp-57-2-201]\]. In protozoal infections these mast cells are characterized by degranulation and the production of pro-inflammatory mediators, such as TNF-α \[[@b13-kjp-57-2-201]\]. The mast cell activator, compound 48/80, up-regulated Th1 cytokine mRNA (IFN-γ, IL-12p40, TNF-α), and the mast cell stabilizer, disodium cromoglycate, increased Th2 cytokine mRNA (IL-4, IL-10) \[[@b12-kjp-57-2-201]\].

Mast cells are effector cells involved in clearance of parasites including *Trichomonas vaginalis* (*T. vaginalis*) \[[@b6-kjp-57-2-201]\]. We observed that rat peritoneal mast cells (RPMCs) were involved in the inflammatory response to *T. vaginalis* infection. Increased release of histamine and TNF-α were observed in RPMC-stimulated *T. vaginalis* ESP or live trichomonads \[[@b19-kjp-57-2-201]\]. Activation of mast cells has been reported to trigger production of cytokines and inflammatory mediators by protozoan parasites such as *Plasmodium* sp., *Leishmania* sp., and *T. gondii* \[[@b12-kjp-57-2-201]\].

Several protozoan parasites have evolved strategies to evade NO-mediated anti-microbicidal activity. Inducible nitric oxide synthase (iNOS)-derived NO can inhibit leucocyte adhesion in the micro-vasculature during ongoing inflammation. *T. gondii* infection partially inhibits NO production by murine macrophages and thus promotes parasite survival in phagocytic cells \[[@b12-kjp-57-2-201],[@b20-kjp-57-2-201],[@b21-kjp-57-2-201]\]. *Leishimania* sp. and *Trypanosoma cruzi* are known to inhibit iNOS expression \[[@b22-kjp-57-2-201],[@b23-kjp-57-2-201]\]. We investigated HMC-1 cells were treated with *T. gondii* lysate to determine whether *T. gondii* infection affects NO production. Increased iNOS mRNA and NO production were observed at 3 hr PI and it then declined by 6 hr.

Mast cells induce recruitment of other immune cells to initiate inflammation. In the present study, we observed that *T. gondii* lysate stimulated the production of chemokines (CXCL8, MCP-1), cytokines (TNF-α, IL-4) and NO production in HMC-1 cells. Therefore, activated mast cells by *T. gondii* lysate may be involved in innate and adaptive immune responses against *T. gondii* infection.
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![Increased production of IL-8, MCP-1, TNF-α and IL-4 mRNAs and proteins by HMC-1 cells incubated with *T. gondii* lysate. HMC-1 cells were pretreated with IFN-γ for 1 hr and then stimulated with *T. gondii* lysate or LPS. mRNA expression of each cytokine (A) and cytokine level (B) were increased. CXCR1 and CXCR2 was measured by western blotting with monoclonal antibodies to each receptor after 1 hr of treatment with *T. gondii* lysate. PMA +A23187 was used as positive control. M, culture supernatant of HMC-1 alone; M\*, culture supernatant of HMC-1 treated with IFN-γ; TgL, *T. gondii* lysate. \**P*\<0.05 vs HMC-1 treated with IFN-γ.](kjp-57-2-201f1){#f1-kjp-57-2-201}

![iNOS mRNA and nitric oxide (NO) productions were up-regulated by HMC-1 cells stimulated with *T. gondii* lysate. HMC-1 cells were pretreated with IFN-γ for 1 hr and then stimulated with *T. gondii* lysate or LPS. iNOS mRNA (A) and NO production (B) were determined after 3 hr, 6 hr, 18 hr, and 24 hr of incubation. NO production was measured with Griess reagent. PMA +A23187 was used as positive control. M, culture supernatant of HMC-1 cells alone; M\*, culture supernatant of HMC-1 cells treated with IFN-γ; TgL, *T. gondii* lysate. \**P*\<0.05 vs HMC-1 cells treated with IFN-γ.](kjp-57-2-201f2){#f2-kjp-57-2-201}
